ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HCM Hutchmed (china) Limited

304.00
0.00 (0.00%)
Last Updated: 05:07:22
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Hutchmed (china) Limited HCM London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 304.00 05:07:22
Open Price Low Price High Price Close Price Previous Close
312.00 304.00 312.00 304.00
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Recent News

Date Time Source Heading
4/22/202403:30UK RNSHutchmed (China) Limited Vesting of Awards Under the LTIP
4/08/202403:30UK RNSHutchmed (China) Limited 2023 Annual Report and Notice of..
4/05/202403:30UK RNSHutchmed (China) Limited Data to be Presented at AACR..
4/02/202404:32ALNCNewsHutchmed endometrial cancer treatment application accepted..
4/02/202401:00UK RNSHutchmed (China) Limited HUTCHMED and Innovent Announce NDA..
3/28/202406:08ALNCNewsHutchmed lung cancer treatment accepted for review in China
3/28/202402:00UK RNSHutchmed (China) Limited Savolitinib sNDA Accepted in China
3/22/202405:09ALNCNewsHutchmed begins registration stage for sovleplenib phase 2/3..
3/22/202402:16ALNCNews*CORRECT: Hutchmed China initiates registration for phase 3..
3/22/202402:00UK RNSHutchmed (China) Limited Initiation of Registration Stage of..
3/14/202404:00UK RNSHutchmed (China) Limited LTIP and Share Option Scheme
3/05/202402:30UK RNSHutchmed (China) Limited Vesting of awards under the LTIP
2/28/202411:31ALNCNewsEARNINGS: Hutchmed revenue surges, Craven House's loss..
2/28/202406:45UK RNSHutchmed (China) Limited Publication of Form 20-F
2/28/202405:30UK RNSHutchmed (China) Limited 2023 Full Year Results and Business..
2/07/202403:50ALNCNewsHutchmed hails fruquintinib trial results for gastric cancer..
2/07/202401:00UK RNSHutchmed (China) Limited Presentation of Phase III Data on..
2/02/202403:52ALNCNewsHutchmed says Inmagene exercises option to licence drug..
2/02/202402:37UK RNSHutchmed (China) Limited Inmagene Exercises Option for Two..
2/01/202402:30UK RNSHutchmed (China) Limited HUTCHMED to Announce 2023 Final..
1/30/202403:20ALNCNewsHutchmed celebrates cancer drug approval in hometown of Hong..
1/30/202401:12UK RNSHutchmed (China) Limited HUTCHMED Receives Marketing..
1/11/202404:17ALNCNewsTOP NEWS: Hutchmed Sovleplenib accepted for review by China..
1/11/202401:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
12/29/202302:30UKREGHutchmed (China) Limited Total Voting Rights
12/29/202302:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
12/21/202305:36ALNCNewsIN BRIEF: Hutchmed China renews deals with "substantial"..
12/21/202304:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
12/13/202307:56ALNCNewsHutchmed completes enrolment for fruquintinib trial
12/13/202301:00RNSNONHutchmed (China) Limited Inclusion in National Reimbursement..
12/07/202304:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
12/01/202301:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
11/30/202302:30UKREGHutchmed (China) Limited Total Voting Rights
11/09/202306:16ALNCNewsHutchmed hails Takeda's fruquintinib approval from US for..
11/09/202301:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
10/24/202303:30UKREGHutchmed (China) Limited Vesting of awards under the LTIP
10/16/202303:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
9/29/202304:12ALNCNewsHutchmed notes Takeda submits fruquintinib drug application..
9/29/202303:30UKREGHutchmed (China) Limited Total Voting Rights
9/29/202303:30RNSNONHutchmed (China) Limited NDA Submission for Fruquintinib in..
9/14/202303:30UKREGHutchmed (China) Limited Director's Share Dealing
9/12/202304:26ALNCNewsIN BRIEF: Hutchmed China finalises patient enrolment for..
9/12/202303:30RNSNONHutchmed (China) Limited Phase IIIb Savolitinib Results at..
9/12/202301:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
8/31/202303:30UKREGHutchmed (China) Limited Total Voting Rights
8/29/202303:30ALNCNewsIN BRIEF: China grants Hutchmed's savolitinib breakthrough..
8/29/202301:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
8/21/202302:46ALNCNewsHutchmed China hails trial on sovleplenib meeting primary..
8/21/202301:00UKREGHutchmed (China) Limited Sovleplenib Phase 3 Study Meets..
8/07/202303:30UKREGHutchmed (China) Limited Exercise of Share Options by a..

Your Recent History

Delayed Upgrade Clock